Use of bioengineered human commensal gut bacteria‐derived microvesicles for mucosal plague vaccine delivery and immunization
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of bioengineered human commensal gut bacteria‐derived microvesicles for mucosal plague vaccine delivery and immunization
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 196, Issue 3, Pages 287-304
Publisher
Wiley
Online
2019-04-15
DOI
10.1111/cei.13301
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease
- (2019) Giuseppe Cappellano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual route vaccination for plague with emergency use applications
- (2018) B.D. Moore et al. VACCINE
- Diversity of macaque microbiota compared to the human counterparts
- (2018) Zigui Chen et al. Scientific Reports
- Novel approaches to Neisseria meningitidis vaccine design
- (2017) Myron Christodoulides et al. Pathogens and Disease
- Cospeciation of gut microbiota with hominids
- (2016) A. H. Moeller et al. SCIENCE
- Protecting enzymatic function through directed packaging into bacterial outer membrane vesicles
- (2016) Nathan J. Alves et al. Scientific Reports
- Colitogenic Bacteroides thetaiotaomicron Antigens Access Host Immune Cells in a Sulfatase-Dependent Manner via Outer Membrane Vesicles
- (2015) Christina A. Hickey et al. Cell Host & Microbe
- Plague vaccines and the molecular basis of immunity againstYersinia pestis
- (2014) Lauriane E. Quenee et al. Human vaccines & immunotherapeutics
- Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against β-lactam antibiotics
- (2014) Régis Stentz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- V-antigen homologs in pathogenic gram-negative bacteria
- (2014) Teiji Sawa et al. MICROBIOLOGY AND IMMUNOLOGY
- Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa
- (2014) Teiji Sawa et al. Human Vaccines & Immunotherapeutics
- Efficacy of Primate Humoral Passive Transfer in a Murine Model of Pneumonic Plague Is Mouse Strain-Dependent
- (2014) V. A. Graham et al. Journal of Immunology Research
- Defining the Bacteroides Ribosomal Binding Site
- (2013) Udo Wegmann et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Prophylaxis and therapy of plague
- (2013) Petra CF Oyston et al. Expert Review of Anti-Infective Therapy
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- The natural history and incidence of Yersinia pestis and prospects for vaccination
- (2012) E. D. Williamson et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
- (2011) Xilian Bai et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague
- (2011) E.D. Williamson et al. VACCINE
- Evolutionary Relationships of Wild Hominids Recapitulated by Gut Microbial Communities
- (2010) Howard Ochman et al. PLOS BIOLOGY
- Prospects for new plague vaccines
- (2009) Valentina A Feodorova et al. Expert Review of Vaccines
- N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection
- (2009) Jim Hill et al. VACCINE
- Plague
- (2009) E.D. Williamson VACCINE
- The Macaque Gut Microbiome in Health, Lentiviral Infection, and Chronic Enterocolitis
- (2008) Philip McKenna et al. PLoS Pathogens
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started